December 14, 2012 - ASM Comments on Influenza Viruses Containing the Hemagglutinin from the Goose/Guangdong/1/96 Lineage
The ASM submitted comments in response to the Federal Register Notice, "Influenza Viruses Containing the
Hemagglutinin from the Goose/Guangdong/1/96 Lineage."
December 13, 2012 - ASM Signs onto AFRI Coalition Sequestration Letter
The AFRI Coalition sent a letter to the White House and Congressional Leadership, urging them to find a bipartisan solution to the so called “fiscal cliff” before the end of the year to avoid devastating cuts to R&D.
December 11, 2012 - ASM Signs onto Coalition Sequestration Letter
The ASM signed onto a letter from the Ad Hoc Group for Medical Research Coalition that was sent to all members of the House of Representatives. The letter outlined the coalition's concerns about the impact of continued cuts, including sequestration, on medical research supported by the National Institutes of Health (NIH) and the subsequent negative consequences for the health of all Americans.
December 7, 2012 - ASM Signs onto Coalition Letter Regarding Sequestration
The ASM signed onto a letter regarding the importance of federal research and development (R&D) and the impact that the sequester would have on the future of the U.S. research
. The letter was sent to the President and the House and Senate Leadership.
November 29, 2012 - ASM Signs Clinical Laboratory Coalition Letter to Congress
The ASM signed onto a coalition letter that requests protection of access to Medicare Part B clinical laboratory services and specifically urges legislators to oppose any additional reductions in the Medicare Part B Clinical Laboratory Fee Schedule.
The ASM signed onto a letter regarding the inpending cuts to the biomedical research and public health programs of the NIH, NSF, FDA and CDC.
ASM sent a letter to the Joint Select Committee on Deficit Reduction to urge them to strengthen funding for the Nation's science and public health programs.
The ASM signed onto a letter expressing concerns with several provisions related to National Institutes of Health in the FY 2013 Labor-HHS-Education appropriations bill passed by the House Labor-HHS Subcommittee.
July 12, 2012 - ASM Comments on FDA Draft Guidance for Industry
The ASM submitted comments to the Food and Drug Administration on two Guidance Documents for Industry, "The Judicious Use of Medically Important Antimicrobial Drugs in Food-Producing Animals" and "New Animal Drugs and New Animal Drug Combination Products Administered in or on Medicated Feed or Drinking Water of Food-Producing Animals: Recommendations for Drug Sponsors for Voluntarily Aligning Product Use Conditions with GFI."
Vickie Baselski, Chair of the PSAB Professional Affairs Committee, submitted ASM’s recommendations with respect to payment determinations to the Center for Medicare & Medicaid (CMS) for select new Current Procedural Terminology (CPT) codes to be included in the 2013 Medicare Clinical Laboratory Fee Schedule. Of particular interest are several new multi target respiratory virus CPT codes, new codes for genotype analysis of CMV and Hepatitis B, and a new code for cell enumeration using immunologic selection and identification in fluid specimen.
July 12, 2012 - ASM Signs onto Coalition Letter Regarding the Budget Control Act and Sequestration
The ASM signed onto an Ad Hoc Group for Medical Research letter sent to all Members of Congress, the White House, the Department of Health and Human Services (HHS), the Office of Management and Budget (OMB), and the Office of Science and Technology Policy (OSTP) expressing grave concern about the impact of the pending sequestration mandated by the Budget Control Act on medical research supported by the NIH and the subsequent negative consequences this funding cut will have on the health of all Americans by slowing scientific progress against disease and disability.
June 13, 2012 - ASM Supports National Science Foundation Funding
The ASM, joined by more than one hundred universities and scientific societies, signed a letter sent to the Senate urging them to resist attempts to reduce funding for the NSF in the FY 2013 Commerce, Justice and Science (CJS) appropriations bill.
June 8, 2012 - ASM Supports Funding for BARDA
The ASM signed onto a letter sent to Congress supporting Biomedical Advanced Research and Development Authority (BARDA) funding. The letter requested at least $547 million for Fiscal Year (FY) 2013, the level requested by the Administration.
June 6, 2012 - ASM Comments on Draft Recommendations for Identification of Chronic HCV Infection
The ASM sent comments to CDC on the Federal Register
notice, Recommendations for the Identification of Hepatitis C Virus (HCV) Chronic Infection
. These draft recommendations are intended to increase the proportion of persons with chronic HCV who are properly diagnosed and treated. ASM’s comments address specific aspects of the laboratory testing process for HCV.
June 6, 2012 - ASM Supports Agricultural Research Foundation
The ASM endorsed a letter sent to the House Committee on Agriculture supporting the establishment of a Foundation for Food and Agriculture Research (FFAR.) The letter, signed by more than seventy organizations, urged Congress to follow the lead of the Senate and include language in the Research Title of the 2012 Farm Bill to create FFAR. The Foundation would work to generate additional funding for food and agricultural research, supplement federal investments and appropriations and encourage the development of new private/public partnerships to enhance the USDA’s research mission.
May 24, 2012 - ASM Submits Comments to NAS on Seeking Solutions Conference
The ASM submitted comments to the National Academies in response to their request to submit testimony on a conference the NAS is holding called, "Seeking Solutions: Maximizing American Talent by Advancing Women of Color in Academia." The comments were written by the Committee on Microbiological Issues Impacting Minorities.
May 21, 2012 - ASM Signs Coalition Letters Regarding Travel Restriction Amendments
The ASM signed onto letters to the House
regarding the government travel restriction amendments included in the "21st Century Postal Service Act" and the Digital Accountability and Transparency Act."
May 17, 2012 - ASM Sends Letter to Congress on Government Scientist Travel Restriction Amendments
The ASM sent a letter to members of Congress regarding the government travel restriction amendments included in the "21st Century Postal Service Act" and the Digital Accountability and Transparency Act." If passed, the law would limit the ability of scientists from federal agencies to attend scientific meetings and conferences.
May 12, 2012 - ASM Signs onto Letter Regarding NIH Salary Caps
The ASM joined 160 other organizations in signing a letter urging Congress to restore the salary limit imposed on extramural NIH researchers to Level I of the Executive Pay Scale.
March 16, 2012 - ASM Signs onto Coalition Letter Supporting NIH Funding in FY 2013
The ASM signed onto a letter as a member of the Ad Hoc Group for Medical Research urging Congress to provide the largest possible 302(b) allocation to the FY 2013 Labor, Health and Human Services, Education and Related Agencies Appropriations Subcommittee within the discretionary cap established by the Budget Control Act (BCA).
February 27, 2012 - ASM Signs Coalition Letter Supporting Funding for AFRI in FY 2013
The ASM worked with the AFRI Coalition to write and distribute to Congress a letter supporting the President’s proposed budget of $325 million for the Agriculture and Food Research Initiative (AFRI) in FY 2013.
February 24, 2012 - ASM Comments on NIH RFI on Diversity in the Biomedical Research Workforce
The ASM sent comments to the National Institutes of Health Advisory Committee to the NIH Director Working Group on Diversity in the Biomedical Research Workforce on the RFI NOT-OD-12-031.
February 22, 2012 - ASM Cosigns Letter on Antibiotics Pipeline
The ASM cosigned a February 22 letter to Congress, prepared by the Infectious Diseases Society of America (IDSA), which urges the legislators to address the serious and growing problems of antimicrobial resistance and the dry pipeline for antibiotic research and development in upcoming Food and Drug Administration user fee legislation. The letter also asked Congress to incentivize the development of new related diagnostics and to strengthen federal efforts to promote appropriate use of antibiotics. (Senate Version
February 22, 2012 - ASM Comments on Draft Recreational Water Quality Criteria
ASM submits comments to the EPA on the proposed Recreational Water Quality Criteria (RWQC) for use in managing all US coastal, inland and Great Lakes waters designated for primary contact recreation.
February 16, 2012 - ASM Signs on to CLC Letter Opposing Laboratory Cuts
ASM joined with the Clinical Laboratory Caucus (CLC), a group of laboratory and health care organizations, representing America’s community, regional, and national laboratories and asked key members of Congress to oppose any cuts to the Medicare Part B Clinical Laboratory Fee Schedule as they work to address physician pay cuts. January 25, 2012 - ASM Comments on FDA Cephalosporin Rule
The ASM submitted comments to the Food and Drug Administration on the rule on prudent use of antimicrobial drugs in food animals.
January 24, 2012 - ASM Comments on GRANTS Act
The ASM sent letters to members of the House of Representatives commenting on the Grant Reform and New Transparency (GRANT) Act (H.R. 3433)